Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Hyperparathyroidism, Primary

raloxifene hydrochloride has been researched along with Hyperparathyroidism, Primary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alfadhli, EM1
Akbaba, G; Ates Tutuncu, Y; Berker, D; Guler, S; Isik, S; Ozuguz, U1
Dillon, ML; Frazee, LA1
Farford, B; Moraghan, TJ; Presutti, RJ1
Sugimoto, T1

Reviews

4 review(s) available for raloxifene hydrochloride and Hyperparathyroidism, Primary

ArticleYear
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
    Clinical therapeutics, 2021, Volume: 43, Issue:4

    Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D

2021
Cinacalcet for the treatment of primary hyperparathyroidism.
    American journal of therapeutics, 2011, Volume: 18, Issue:4

    Topics: Bone Density; Bone Density Conservation Agents; Calcimimetic Agents; Calcitonin; Cinacalcet; Diphosphonates; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hyperparathyroidism, Primary; Naphthalenes; Osteoporosis; Raloxifene Hydrochloride

2011
Nonsurgical management of primary hyperparathyroidism.
    Mayo Clinic proceedings, 2007, Volume: 82, Issue:3

    Topics: Cinacalcet; Diet; Diphosphonates; Estrogen Replacement Therapy; Humans; Hyperparathyroidism, Primary; Life Style; Naphthalenes; Raloxifene Hydrochloride; Sclerotherapy; Selective Estrogen Receptor Modulators

2007
[Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Apr-10, Volume: 96, Issue:4

    Topics: Alendronate; Biomarkers; Bone Density Conservation Agents; Calcium; Diagnosis, Differential; Diagnostic Imaging; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Polymorphism, Genetic; Raloxifene Hydrochloride; Receptors, Calcium-Sensing; Selective Estrogen Receptor Modulators; Vitamin D

2007

Trials

1 trial(s) available for raloxifene hydrochloride and Hyperparathyroidism, Primary

ArticleYear
Comparison of alendronate and raloxifene for the management of primary hyperparathyroidism.
    Journal of endocrinological investigation, 2013, Volume: 36, Issue:11

    Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Female; Humans; Hyperparathyroidism, Primary; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride

2013